tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GSK Stock Latest News

TrumpRx website using technology from GoodRx, STAT says
The FlyTrumpRx website using technology from GoodRx, STAT says
2h ago
AZN
BMY
GSK’s H5N1 mRNA Flu Vaccine Trial Reaches Completion: What Investors Should Watch Next
PremiumCompany Announcements
GSK’s H5N1 mRNA Flu Vaccine Trial Reaches Completion: What Investors Should Watch Next
3h ago
GSK
Clear Street says AbbVie move further validates Oruka Therapeutics’ strategy
PremiumThe Fly
Clear Street says AbbVie move further validates Oruka Therapeutics’ strategy
1d ago
GSK
ABBV
GSK: Solid Near‑Term Delivery, Enhanced Shareholder Returns, and Compelling 2031 Growth Upside Support Buy Rating
PremiumRatings
GSK: Solid Near‑Term Delivery, Enhanced Shareholder Returns, and Compelling 2031 Growth Upside Support Buy Rating
1d ago
GSK
Balancing Pipeline Upside and HIV Patent Cliff Risks: Justifying a Hold Rating Despite FX Drag and Valuation Richness
PremiumRatings
Balancing Pipeline Upside and HIV Patent Cliff Risks: Justifying a Hold Rating Despite FX Drag and Valuation Richness
1d ago
GSK
GSK expects dividend of 70p per share for FY26
PremiumThe FlyGSK expects dividend of 70p per share for FY26
1d ago
GSK
GSK reports Q4 core EPS 25.5p, up 14% at CER
Premium
The Fly
GSK reports Q4 core EPS 25.5p, up 14% at CER
1d ago
GSK
GSK sees FY26 core EPS growth 7%-9%
Premium
The Fly
GSK sees FY26 core EPS growth 7%-9%
1d ago
GSK
GSK sees 2031 sales over GBP 40B
PremiumThe Fly
GSK sees 2031 sales over GBP 40B
1d ago
GSK
Wave Life Sciences price target raised to $43 from $40 at Canaccord
PremiumThe Fly
Wave Life Sciences price target raised to $43 from $40 at Canaccord
2d ago
GSK
WVE
Wave Life Sciences price target raised to $50 from $47 at Clear Street
PremiumThe Fly
Wave Life Sciences price target raised to $50 from $47 at Clear Street
3d ago
GSK
WVE
Wave Life Sciences regains full rights to WVE-006
PremiumThe Fly
Wave Life Sciences regains full rights to WVE-006
3d ago
GSK
WVE
GSK Earnings this Week: How Will it Perform?
PremiumPre-EarningsGSK Earnings this Week: How Will it Perform?
3d ago
GSK
The Week That Was, The Week Ahead: Macro and Markets, Feb. 1
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, Feb. 1
4d ago
C
CG
GSK Advances Shigella Vaccine Program With Completed Phase 2 Trial in African Infants
Premium
Company Announcements
GSK Advances Shigella Vaccine Program With Completed Phase 2 Trial in African Infants
6d ago
GSK
GSK’s Long-Term Nucala Study in EGPA Nears the Finish Line: What Investors Should Know
PremiumCompany Announcements
GSK’s Long-Term Nucala Study in EGPA Nears the Finish Line: What Investors Should Know
6d ago
GSK
GSK Advances Liver Disease Pipeline With New Efimosfermin Alfa Trial
PremiumCompany Announcements
GSK Advances Liver Disease Pipeline With New Efimosfermin Alfa Trial
8d ago
GSK
GSK’s Benlysta Real‑World Study Nears the Finish Line: What Investors Should Watch
PremiumCompany Announcements
GSK’s Benlysta Real‑World Study Nears the Finish Line: What Investors Should Watch
9d ago
GSK
GSK initiated with a Neutral at Citi
PremiumThe Fly
GSK initiated with a Neutral at Citi
9d ago
GSK
GSK’s RSV vaccine receives European approval for expanded use
PremiumThe FlyGSK’s RSV vaccine receives European approval for expanded use
10d ago
GSK
Drugmakers use AI to help progress through trials, submissions, Reuters says
Premium
The Fly
Drugmakers use AI to help progress through trials, submissions, Reuters says
10d ago
GSK
LLY
GSK announces China’s NMPA approved new indication for Trelegy Ellipta
Premium
The Fly
GSK announces China’s NMPA approved new indication for Trelegy Ellipta
13d ago
GSK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >